跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ambdart - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ambdart
Approved
STANDARD
Ambdart
Globela Pharma Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
442e3e17b35b429b
Company
Globela Pharma Private Limited
Type
Standard
Approval Details
Approval Id
442e3e17b35b429b
Drug Approval Philippines Name
Ambdart
Product Name
Ambdart
Registration Number
DRP-10763-02
Brand Name
Ambdart
Generic Name
Dutasteride + Tamsulosin hydrochloride
Dosage Form
400 mcg
Dosage Strength
500 mcg
Manufacturer
Globela Pharma Private Limited
Importer
AMB HK Enterprises Inc.
Distributor
PhilRx Pharma, Inc.
Issuance Date
26 January 2022
Expiry Date
16 November 2026
Pharmacologic Category
Alpha-adrenoreceptor Antagonists
Classification
Capsule
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
442e3e17b35b429b
Type
Standard
Back to Philippines FDA Approvals